Celltrion Pharm, Inc. (KOSDAQ:068760)

Celltrion Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Feb 26, 2026	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Market Capitalization	3,123,008	8,705,449	1,423,608	2,161,702	2,080,517	794,235
Market Cap Growth	41.33%	511.51%	-34.14%	3.90%	161.95%	110.08%
Enterprise Value	-	8,872,310	1,575,734	2,314,790	2,217,034	956,310
Last Close Price	71800.00	195550.83	31979.53	48592.97	46832.91	17930.71
PE Ratio	123.08	415.74	165.49	-	132.39	-
PS Ratio	11.37	37.27	8.21	14.72	15.31	7.58
PB Ratio	10.32	28.96	5.08	8.01	7.09	2.87
P/TBV Ratio	11.67	32.78	5.81	9.20	8.04	3.29
P/FCF Ratio	-	-	-	304.21	-	-
P/OCF Ratio	109.83	240.18	51.11	151.03	-	-
EV/Sales Ratio	-	37.99	9.08	15.76	16.32	9.12
EV/EBITDA Ratio	-	239.14	56.76	145.79	106.35	-
EV/EBIT Ratio	-	375.45	106.91	731.16	257.40	-
EV/FCF Ratio	-	-	-	325.75	-	-
Debt / Equity Ratio	0.63	0.64	0.58	0.54	0.49	0.50
Debt / EBITDA Ratio	4.48	5.20	5.83	9.26	6.92	-
Debt / FCF Ratio	-	-	-	20.68	-	-
Net Debt / Equity Ratio	0.52	0.54	0.53	0.51	0.47	0.46
Net Debt / EBITDA Ratio	3.67	4.40	5.35	8.68	6.63	-42.51
Net Debt / FCF Ratio	-72.05	-28.49	-56.42	19.40	-12.30	-4.53
Asset Turnover	0.52	0.46	0.38	0.32	0.30	0.24
Inventory Turnover	4.20	3.65	2.96	1.99	1.19	0.90
Quick Ratio	0.92	0.93	1.02	0.98	1.06	1.27
Current Ratio	1.24	1.25	1.27	1.38	1.70	2.37
Return on Equity (ROE)	8.91%	7.21%	3.13%	-3.33%	5.51%	-9.00%
Return on Assets (ROA)	3.41%	2.90%	1.99%	0.43%	1.18%	-2.18%
Return on Invested Capital (ROIC)	6.25%	5.30%	3.43%	0.75%	2.06%	-3.76%
Return on Capital Employed (ROCE)	7.90%	6.50%	4.60%	1.00%	2.50%	-4.10%
Earnings Yield	0.83%	0.24%	0.60%	-0.43%	0.76%	-2.66%
FCF Yield	-0.07%	-0.07%	-0.18%	0.33%	-0.54%	-3.56%
Buyback Yield / Dilution	-0.23%	-0.18%	-0.40%	-1.38%	-18.02%	-33.27%

Updated May 14, 2021. Source: S&P Global Market Intelligence. Standard template. Financial Sources.